Resideo Technologies
REZI
17.56
-1.36
-7.19%
Resideo Technologies
US · REZI
#2555 by market cap
Listed 1970
17.56
-1.36
-7.19%
Live - 5344 symbols - heartbeat 5s ago
· 2026-10-08 07:40
Pre-market
17.56
0.00%
After-hours
17.54
-0.11%
- Market cap
- 2.67B
- P/E (TTM)i
- 6.86
- P/Bi
- 1.06
- EPSi
- -3.77
- Div yieldi
- 0.00%
- 52W posi
- 2%
Reader sentiment
Are you bullish or bearish on REZI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.71, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +10.52% YoY
Margins
- Gross margin
- 29.39%
- Operating margin
- 8.58%
- Net margin
- -7.52%
Key ratios & quality
- Enterprise valuei
- 5.23B
- Altman Z-Scorei
- 1.71
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.83B | 4.99B | 5.07B | 5.85B | 6.37B | 6.24B | 6.76B | 7.47B |
| Gross profit | 1.43B | 1.28B | 1.31B | 1.58B | 1.77B | 1.70B | 1.90B | 2.20B |
| Selling & admin expenses | 932.00M | 932.00M | 925.00M | 909.00M | 974.00M | 960.00M | 1.14B | 1.27B |
| Research & development | -- | 87.00M | 77.00M | 86.00M | 111.00M | 109.00M | 111.00M | 167.00M |
| Operating profit | 170.00M | 258.00M | 311.00M | 559.00M | 646.00M | 589.00M | 572.00M | 641.00M |
| Pretax profit | 104.00M | 71.00M | 101.00M | 353.00M | 418.00M | 313.00M | 221.00M | -457.00M |
| Tax | -301.00M | 35.00M | 64.00M | 111.00M | 135.00M | 103.00M | 105.00M | 70.00M |
| Net profit | 405.00M | 36.00M | 37.00M | 242.00M | 283.00M | 210.00M | 116.00M | -527.00M |
| Basic EPS | 3 | 0 | 0 | 2 | 2 | 1 | 1 | -4 |
| Diluted EPS | 3.30 | 0.29 | 0.29 | 1.63 | 1.90 | 1.42 | 0.61 | -3.77 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 1.77B | 1.94B | 1.86B | 1.90B | 1.91B | 1.98B |
| Gross profit | 511.00M | 569.00M | 556.00M | 560.00M | 551.00M | 595.00M |
| Selling & admin expenses | 306.00M | 319.00M | 324.00M | 317.00M | 340.00M | 332.00M |
| Research & development | 35.00M | 41.00M | 44.00M | 47.00M | 48.00M | 48.00M |
| Operating profit | 140.00M | 179.00M | 157.00M | 165.00M | 132.00M | 184.00M |
| Pretax profit | 15.00M | -738.00M | 110.00M | 156.00M | 55.00M | 166.00M |
| Tax | 9.00M | 87.00M | -46.00M | 20.00M | 17.00M | 69.00M |
| Net profit | 6.00M | -825.00M | 156.00M | 136.00M | 38.00M | 97.00M |
| Basic EPS | 0 | -6 | 1 | 1 | 0 | 1 |
| Diluted EPS | -0.02 | -5.59 | 0.85 | 0.73 | 0.17 | 0.51 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.81B | 1.79B | 2.23B | 2.54B | 2.50B | 2.74B | 3.17B | 3.36B |
| Cash & ST investments | 265.00M | 122.00M | 517.00M | 775.00M | 326.00M | 636.00M | 692.00M | 661.00M |
| Inventory | 628.00M | 671.00M | 672.00M | 740.00M | 975.00M | 941.00M | 1.24B | 1.35B |
| Total assets | 4.97B | 5.13B | 5.61B | 5.85B | 6.39B | 6.65B | 8.20B | 8.43B |
| Total current liabilities | 1.49B | 1.49B | 1.54B | 1.49B | 1.55B | 1.53B | 1.79B | 1.76B |
| Short-term debt | 22.00M | 22.00M | 7.00M | 42.00M | 49.00M | 39.00M | 51.00M | 57.00M |
| Long-term debt | 1.18B | 1.16B | 1.16B | 1.22B | 1.40B | 1.40B | 1.98B | 3.17B |
| Total liabilities | 3,439,000,000.00 | 3,526,000,000.00 | 3,617,000,000.00 | 3,601,000,000.00 | 3,858,000,000.00 | 3,896,000,000.00 | 4,890,000,000.00 | 5,516,000,000.00 |
| Total equity | 1.53B | 1.60B | 1.99B | 2.25B | 2.53B | 2.75B | 3.31B | 2.92B |
| Retained earnings | 2.00M | 38.00M | 75.00M | 317.00M | 600.00M | 810.00M | 907.00M | 345.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 3.06B | 3.39B | 3.07B | 3.36B | 3.17B | 3.83B |
| Cash & ST investments | 577.00M | 753.00M | 345.00M | 661.00M | 438.00M | 549.00M |
| Inventory | 1.23B | 1.26B | 1.33B | 1.35B | 1.36B | 1.39B |
| Total assets | 8.07B | 8.52B | 8.19B | 8.43B | 8.21B | 8.78B |
| Total current liabilities | 1.58B | 3.38B | 1.63B | 1.76B | 1.53B | 1.72B |
| Short-term debt | 51.00M | -- | 55.00M | 57.00M | 57.00M | 59.00M |
| Long-term debt | 1.98B | 1.98B | 3.17B | 3.17B | 3.17B | 3.56B |
| Total liabilities | 4,727,000,000.00 | 5,901,000,000.00 | 5,417,000,000.00 | 5,516,000,000.00 | 5,285,000,000.00 | 5,775,000,000.00 |
| Total equity | 3.35B | 2.61B | 2.77B | 2.92B | 2.92B | 3.01B |
| Retained earnings | 904.00M | 71.00M | 218.00M | 345.00M | 374.00M | 463.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 462.00M | 23.00M | 244.00M | 315.00M | 152.00M | 440.00M | 444.00M | -1.14B |
| Depreciation & amortization | 66.00M | 80.00M | 86.00M | 88.00M | 94.00M | 98.00M | 144.00M | 195.00M |
| Free cash flow | 381.00M | -72.00M | 174.00M | 252.00M | 67.00M | 335.00M | 364.00M | -1.25B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 279.00M | 0 | 0 | -58.00M | -18.00M | -29.00M |
| Ending cash balance | 265.00M | 122.00M | 517.00M | 779.00M | 329.00M | 637.00M | 693.00M | 662.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | -65.00M | 200.00M | -1.57B | 299.00M | -145.00M | 148.00M |
| Depreciation & amortization | 47.00M | 49.00M | 49.00M | 50.00M | 51.00M | 50.00M |
| Free cash flow | -96.00M | 180.00M | -1.60B | 262.00M | -181.00M | 119.00M |
| Dividends paid | -9.00M | -8.00M | -9.00M | -- | -9.00M | -8.00M |
| Stock buybacks / issuance | -15.00M | -1.00M | -7.00M | -6.00M | -32.00M | -1.00M |
| Ending cash balance | 578.00M | 754.00M | 346.00M | 662.00M | 440.00M | 949.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 19.58 | 2.30 | 2.06 | 11.40 | 11.84 | 7.96 | 3.26 | -21.36 |
| ROA %i | 8.58 | 0.71 | 0.69 | 4.22 | 4.62 | 3.22 | 1.23 | -6.76 |
| ROIC %i | 12.84 | 3.13 | 2.80 | 8.29 | 8.61 | 6.21 | 3.42 | -8.66 |
| 5-year avg ROE %i | -- | -- | 3.14 | 4.19 | 9.44 | 7.11 | 7.30 | 2.62 |
| EBIT margin %i | 10.21 | 2.81 | 3.23 | 6.86 | 7.47 | 6.06 | 4.47 | -4.31 |
| FCF / sales %i | 7.89 | -- | 3.43 | 4.31 | 1.05 | 5.37 | 5.38 | -- |
| Current ratioi | 1.21 | 1.19 | 1.45 | 1.70 | 1.62 | 1.80 | 1.77 | 1.91 |
| Quick ratioi | 0.73 | 0.63 | 0.90 | 1.11 | 0.86 | 1.06 | 0.96 | 0.99 |
| Debt / assetsi | 24.16 | 23.01 | 20.71 | 21.56 | 22.75 | 21.60 | 24.81 | 38.23 |
| LT debt / equityi | 76.91 | 72.28 | 57.95 | 54.17 | 55.52 | 50.78 | 70.15 | 130.06 |
| Interest coveragei | -- | 2.03 | 2.60 | 8.35 | 8.21 | 5.82 | 3.73 | -2.39 |
| Revenue CAGR (3Y) %i | 5.13 | 3.84 | 3.92 | 6.59 | 8.49 | 7.17 | 4.97 | 5.46 |
| Net income CAGR (3Y) %i | 40.19 | -41.19 | -- | -15.77 | 98.84 | 78.38 | -21.74 | -- |
| FCF CAGR (3Y) %i | 85.18 | -- | -- | -12.87 | -- | 24.40 | 13.04 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 1.60 | -33.01 | -26.24 | -21.36 | -20.09 | 16.28 |
| ROA %i | 0.62 | -9.89 | -8.30 | -6.76 | -6.55 | 4.38 |
| ROIC %i | 2.60 | -16.52 | -11.29 | -8.66 | -8.31 | 10.39 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.63 | -7.19 | -6.13 | -4.31 | -3.41 | 8.70 |
| FCF / sales %i | 4.07 | 5.27 | -- | -- | -- | -- |
| Current ratioi | 1.94 | 1.00 | 1.88 | 1.91 | 2.07 | 2.22 |
| Quick ratioi | 1.03 | 0.56 | 0.91 | 0.99 | 1.01 | 1.02 |
| Debt / assetsi | 25.19 | 23.29 | 39.37 | 38.23 | 39.26 | 41.21 |
| LT debt / equityi | 69.21 | 93.01 | 138.44 | 130.06 | 129.71 | 141.05 |
| Interest coveragei | 2.75 | -5.22 | -4.07 | -2.39 | -1.66 | 3.72 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- ADI Global Distribution is the largest reported line at 64.92% of revenue, across 2 reported segments.
- Products and Solutions follows at 35.08%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
ADI Global Distribution64.92%
Products and Solutions35.08%
Quote time 2026-10-08 07:40:19 · For reference only, not investment advice and not tailored to your situation.